Delivery Order SPE2DX22D0010-SPE2D825FCV31

Award Date 1/19/25
Potential Completion Date 1/21/25
Potential Value $3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,796.11, is for the delivery of Oxycontin tablets (40mg) and has a completion date of March 31, 2025. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,219.48 firm fixed-price delivery order is for the supply of Oxycontin 20mg tablets, with a completion date of December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is a delivery order with a firm fixed price awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,968.40, is for the delivery of Oxycontin tablets 20mg. The award was made by the Defense Logistics Agency (DLA), which is a defense agency that supports the U.S. military's medical and pharmaceutical needs. The contract has an ultimate completion date of June 16, 2025 and does not have a...
This federal contract award, valued at $2,429.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which has a May 2025 completion date, is for the delivery of Oxycontin tablets (40mg) and is structured as a firm fixed-price delivery order. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $2,507.10, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of...
This federal contract award, valued at $1,698.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,568,104,363 units of Oxycontin ER 20 mg tablets, with a completion date of May 2, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,853.30, is for the delivery of 100 tablets of OxyContin ER 40 mg and has an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026, which covers a...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,957.26 firm-fixed price contract is for the delivery of 30mg Oxycontin tablets, a pain management pharmaceutical. The contract has a period of performance through May 30, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $3,181.96 firm fixed price delivery order is for the supply of Oxycontin tablets, a pain management pharmaceutical. The contract has an ultimate completion date of June 23, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DX22D0010|SPE2D825FCW36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $2,064.45, is for the delivery of Oxycontin tablets (40mg) and has an ultimate completion date of January 22, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D825FCV31
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,038.10, is for the delivery of Oxycontin tablets (20mg) and has a completion date of January 21, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 10:20 AM